Loading market dashboard
Akoya Biosciences, Inc.
AKYAHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Akoya Biosciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $112.50M | $95.58M - $129.00M | -$58.31M | -$0.51 | 1 |
| Dec 2028 | $103.30M | $87.77M - $118.45M | -$53.54M | -$0.56 | 1 |
| Dec 2027 | $99.03M | $97.12M - $100.95M | -$51.33M | -$0.607 | 2 |
| Dec 2026 | $91.85M | $78.04M - $105.32M | -$47.61M | -$0.68 | 4 |
| Dec 2025 | $83.42M | $82.34M - $85.21M | -$43.24M | -$0.809 | 2 |
| Dec 2024 | $81.85M | $80.68M - $82.50M | -$42.42M | -$1.096 | 5 |
| Dec 2023 | $93.22M | $79.20M - $106.89M | -$48.31M | -$1.223 | 2 |
| Dec 2022 | $74.09M | $72.64M - $75.64M | -$35.04M | -$1.784 | 2 |
| Dec 2021 | $54.44M | $52.41M - $57.87M | -$25.21M | -$1.451 | 3 |